Front. Pharmacol. Frontiers in Pharmacology Front. Pharmacol. 1663-9812 Frontiers Media S.A. 846668 10.3389/fphar.2022.846668 Pharmacology Correction Corrigendum: The Therapeutic Principle of Combined Strengthening Qi and Eliminating Pathogens in Treating Middle-Advanced Primary Liver Cancer: A Systematic Review and Meta-Analysis She et al. Corrigendum: The Therapeutic Principle of CMFs in PLC She Yingqi 1 † Huang Qinfeng 2 † Ye Zhen 1 Hu Yu 1 Wu Mingquan 3 Qin Kaihua 4 Wei Ailing 5 Yang Xin 1 Liu Yuyao 6 Zhang Cuihan 6 Ye Qiaobo 1 * 1 School of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, China 2 Department of Oncology, The First Affiliated Hospital, Guangxi University of Chinese Medicine, Nanning, China 3 Department of Pharmacy, Sichuan Provincial Orthopedic Hospital, Chengdu, China 4 Health Preservation and Rehabilitation College, Chengdu University of Traditional Chinese Medicine, Chengdu, China 5 Department of Liver Disease, The First Affiliated Hospital, Guangxi University of Chinese Medicine, Nanning, China 6 Pharmacy College, Chengdu University of Traditional Chinese Medicine, Chengdu, China

Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland

 *Correspondence: Qiaobo Ye, yeqiaobo@cdutcm.edu.cn

These authors contributed equally to this work

This article was submitted to Ethnopharmacology, a section of the journal Frontiers in Pharmacology

 04 02 2022 2022 13 846668 31 12 2021 18 01 2022 Copyright © 2022 She, Huang, Ye, Hu, Wu, Qin, Wei, Yang, Liu, Zhang and Ye. 2022 She, Huang, Ye, Hu, Wu, Qin, Wei, Yang, Liu, Zhang and Ye

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

 A Corrigendum on The Therapeutic Principle of Combined Strengthening Qi and Eliminating Pathogens in Treating Middle-Advanced Primary Liver Cancer: A Systematic Review and Meta-Analysis by She, Y., Huang, Q., Ye, Z., Hu, Y., Wu, M., Qin, K., Wei, A., Yang, X., Liu, Y., Zhang, C. and Ye, Q. (2021). Front. Pharmacol. 12:714287. doi: 10.3389/fphar.2021.714287 Chinese medicinal formulas transcatheter arterial chemoembolization drastic medicinals therapeutic principle primary liver cancer meta-analysis

In the published article, there was an error in affiliation 2. Instead of “Department of Oncology, The First Affiliated Hospital, Guangxi University of Chinese Medicine, Chengdu, China”, it should be “Department of Oncology, The First Affiliated Hospital, Guangxi University of Chinese Medicine, Nanning, China”.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.